Imaging of Neuroendocrine Tumors

Publication date: Available online 20 June 2017
Source:Endocrinology and Metabolism Clinics of North America
Author(s): Run Yu, Ashley Wachsman

Teaser

Imaging is critical in the diagnosis, prognosis, and management of neuroendocrine tumors (NETs). NETs share common imaging features, but each type exhibits unique features. Computed tomography scans or MRI of the abdomen are used to assess tumor burden routinely. Functional imaging with octreotide scan or gallium-68 somatostatin analog PET is used selectively to confirm diagnosis and guide therapy. Clinicians and radiologists should be familiar with the indications and interpretations of imaging modalities. Novel functional imaging modalities likely will be developed to detect small NETs, predict prognosis, guide therapeutic choices, and design novel therapies.


http://ift.tt/2t0elR1